| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P356 | DOI | 10.1111/CTR.13151 |
| P698 | PubMed publication ID | 29112283 |
| P50 | author | Yu-Min Li | Q89849086 |
| P2093 | author name string | Jun Wang | |
| Wei Chen | |||
| Nan Yao | |||
| Hong-Peng Wang | |||
| Guang-Tao Min | |||
| P2860 | cites work | Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: A propensity score-based analysis | Q24658602 |
| Meta-analysis in clinical trials | Q27860779 | ||
| Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
| The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration | Q28131636 | ||
| Quantitative synthesis in systematic reviews | Q29614894 | ||
| Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma | Q31111026 | ||
| Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis | Q33589014 | ||
| Inflammatory markers as selection criteria of hepatocellular carcinoma in living-donor liver transplantation | Q33718321 | ||
| Elevated preoperative neutrophil-to-lymphocyte ratio can predict poor survival in early stage gastric cancer patients receiving radical gastrectomy: The Fujian prospective investigation of cancer (FIESTA) study | Q33776722 | ||
| Preoperative Neutrophil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative Resection. | Q33912315 | ||
| Retracted: A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation | Q34038193 | ||
| Preoperative neutrophil-to-lymphocyte ratio is a predictor of recurrence following thermal ablation for recurrent hepatocellular carcinoma: a retrospective analysis | Q34374208 | ||
| Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolization | Q35151707 | ||
| Prognostic significance of the neutrophil-to-lymphocyte ratio in primary liver cancer: a meta-analysis | Q35161694 | ||
| A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI) | Q35933166 | ||
| Pretreatment neutrophil-lymphocyte ratio: an independent predictor of survival in patients with hepatocellular carcinoma | Q36151130 | ||
| Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma | Q36299107 | ||
| Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101 | Q36327007 | ||
| Preoperative Ratio of Neutrophils to Lymphocytes Predicts Postresection Survival in Selected Patients With Early or Intermediate Stage Hepatocellular Carcinoma | Q36567016 | ||
| Clinical significance of pre-operative neutrophil lymphocyte ratio and platelet lymphocyte ratio as prognostic factors for patients with colorectal cancer | Q36640764 | ||
| Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation | Q36684702 | ||
| Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma | Q36756063 | ||
| The systemic inflammatory response as a prognostic factor for advanced hepatocellular carcinoma with extrahepatic metastasis | Q37001415 | ||
| Blood Neutrophil-to-Lymphocyte Ratio Predicts Tumor Recurrence in Patients with Hepatocellular Carcinoma within Milan Criteria after Hepatectomy | Q37124765 | ||
| Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasis. | Q37722175 | ||
| Surgical management of hepatocellular carcinoma. | Q38366587 | ||
| The Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Patients with Unresectable Hepatocellular Carcinoma Treated with Radioembolization. | Q38396459 | ||
| Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies | Q38731362 | ||
| Diabetes mellitus and the neutrophil to lymphocyte ratio predict overall survival in non-viral hepatocellular carcinoma treated with transarterial chemoembolization | Q38933155 | ||
| Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy | Q39112472 | ||
| Neutrophil-to-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma: a Western perspective | Q39333416 | ||
| Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome | Q39485472 | ||
| Preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after reductive surgery plus percutaneous isolated hepatic perfusion for hepatocellular carcinoma: a retrospective analysis | Q39552999 | ||
| Neutrophil to lymphocyte ratio as an indicator of the malignant behaviour of hepatocellular carcinoma | Q40837661 | ||
| Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma | Q40919364 | ||
| Neutrophil and platelet-to-lymphocyte ratio as new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer. | Q42263140 | ||
| Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio | Q42263495 | ||
| Prognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBV-associated hepatocellular carcinoma after radical hepatectomy | Q42270431 | ||
| Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. | Q43725941 | ||
| A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI). | Q43880241 | ||
| Preoperative neutrophil to lymphocyte ratio and prognostic nutritional index predict overall survival after hepatectomy for hepatocellular carcinoma | Q43945807 | ||
| Inflammatory markers are associated with outcome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization | Q44165064 | ||
| Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization. | Q44210220 | ||
| Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis | Q44329423 | ||
| Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection | Q44637461 | ||
| Impact of tumor size, number of tumors and neutrophil-to-lymphocyte ratio in liver transplantation for recurrent hepatocellular carcinoma | Q44696972 | ||
| Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment | Q44934585 | ||
| Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation | Q45358708 | ||
| Pre-treatment neutrophil-to-lymphocyte ratio affects survival in patients with advanced hepatocellular carcinoma treated with sorafenib | Q46703466 | ||
| Lymphocyte to monocyte ratio and neutrophil to lymphocyte ratio are superior inflammation-based predictors of recurrence in patients with hepatocellular carcinoma after hepatic resection. | Q50929188 | ||
| Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma. | Q51711182 | ||
| Inflammation-based Prognostic Score in Patients with Living Donor Liver Transplantation for Hepatocellular Carcinoma. | Q52976254 | ||
| Neutrophil to lymphocyte ratio changes predict small hepatocellular carcinoma survival. | Q53036630 | ||
| Imbalance in systemic inflammation and immune response following transarterial chemoembolization potentially increases metastatic risk in huge hepatocellular carcinoma. | Q53218066 | ||
| Comparisons of financial and short-term outcomes between laparoscopic and open hepatectomy: benefits for patients and hospitals. | Q53487999 | ||
| P433 | issue | 1 | |
| P921 | main subject | liver cancer | Q623031 |
| P577 | publication date | 2017-12-04 | |
| P1433 | published in | Clinical Transplantation | Q15754920 |
| P1476 | title | The pretreatment neutrophil-lymphocyte ratio may predict prognosis of patients with liver cancer: A systematic review and meta-analysis | |
| P478 | volume | 32 |
| Q90603555 | Association between neutrophil-to-lymphocyte ratio and nutritional status in geriatric patients |
| Q99578635 | Neutrophil to lymphocyte ratio and albumin bilirubin grade in hepatocellular carcinoma: A systematic review |
| Q89737464 | Prognostic Roles of Blood Inflammatory Markers in Hepatocellular Carcinoma Patients Taking Sorafenib. A Systematic Review and Meta-Analysis |
| Q89540290 | Prognostic significance of systemic inflammatory markers in esophageal cancer: Systematic review and meta-analysis |
Search more.